Invention Grant
- Patent Title: Reverse cumate repressor mutant
- Patent Title (中): 反向并发阻遏物突变体
-
Application No.: US12331786Application Date: 2008-12-10
-
Publication No.: US07935788B2Publication Date: 2011-05-03
- Inventor: Félix Malenfant , Alaka Mullick
- Applicant: Félix Malenfant , Alaka Mullick
- Applicant Address: CA Ottawa, Ontario
- Assignee: National Research Council of Canada
- Current Assignee: National Research Council of Canada
- Current Assignee Address: CA Ottawa, Ontario
- Main IPC: C07K14/00
- IPC: C07K14/00

Abstract:
Recently, the development of inducible expression systems has involved exploitation of the p-cym operon from Pseudomonas putida. Disclosed herein are novel expression systems and components thereof, which involve the development of a CymR variant with reverse DNA binding activity, such that they exhibit increased affinity for DNA in a presence rather than an absence of an effector molecule such as cumene or an equivalent thereof. Also disclosed are the CymR variant, fusion proteins incorporating such a variant, and its use in the control and expression of polynucleotides. The CymR variant comprises a 142Glu to 142Gly single point mutation of wild type CymR.
Public/Granted literature
- US20090176275A1 EXPRESSION SYSTEM, COMPONENTS THEREOF AND METHODS OF USE Public/Granted day:2009-07-09
Information query